COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ study #60 of 260
6/16 Late treatment study
Kim et al., Korean J Intern Med, doi:10.3904/kjim.2020.224 (Peer Reviewed)
Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019
Source   PDF   Share   Tweet
Small retrospective study of hospitalized patients with 31 lopinavir-ritonavir and 34 HCQ patients, HCQ 400mg once per day, finding no significant difference in clinical response, but more rapid viral clearance with lopinavir-ritonavir.

Kim et al., 6/16/2020, retrospective, South Korea, Asia, peer-reviewed, 7 authors.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit